Timothy J. Maguire
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Timothy J. Maguire has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Martin L. Yarmush
Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, USA
3 shared publications - Rene Schloss
Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, USA
3 shared publications - Andrea Gray
Embry-Riddle Aeronautical University,Software Engineering,Prescott,Arizona
1 shared publication Chris Guaghan
Rutgers University, Piscataway, NJ, USA
1 shared publicationDevasena Manchikalapati
Department of Anesthesiology, New York Methodist Hospital, Brooklyn, USA
1 shared publication- E. Yang
Department of Biomedical Engineering
1 shared publication
Latest Publications
- Open Access
- 16 December 2021
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 12 (3) , 731
Correction to: Alginate-liposomal construct for bupivacaine delivery and MSC function regulation
- 16 December 2021
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 12 (3) , 731
Open AccessCorrection to: Alginate-liposomal construct for bupivacaine delivery and MSC function regulation
- 20 February 2017
- Published by Springer Nature in Biomechanics and Modeling in Mechanobiology
- Vol. 16 (4) , 1095-1102
CFD assessment of the effect of convective mass transport on the intracellular clearance of intracellular triglycerides in macrosteatotic hepatocytes
Donor livers available to transplant for patients with end-stage liver disease are in severe shortage. One possible avenue to expand the donor pool is to recondition livers that would be otherwise discarded due to excessive fat content. Severely steatotic livers (also known as fatty livers) are highly susceptible to ischemia-reperfusion injury and as a result, primary liver non-function post-transplantation. Prior studies in isolated perfused rat livers suggest that “defatting” may be possible in a timeframe of a few hours; thus, it is conceivable that fatty liver grafts could be recovered by machine perfusion to clear stored fat from the organ prior to transplantation. However, studies using hepatoma cells and adult hepatocytes made fatty in culture report that defatting may take several days. Because cell culture studies were done in static conditions, we hypothesized that the defatting kinetics are highly sensitive to flow-mediated transport of metabolites. To investigate this question, we experimentally evaluated the effect of increasing flow rate on the defatting kinetics of cultured HepG2 cells and developed an in silico combined reaction-transport model to identify possible rate-limiting steps in the defatting process. We found that in cultured fatty HepG2 cells, the time required to clear stored fat down to lean control cells can be reduced from 48 to 4–6 h by switching from static to flow conditions. The flow required resulted in a fluid shear of .008 Pa, which did not adversely affect hepatic function. The reaction-transport model suggests that the transport of l-carnitine, which is the carrier responsible for taking free fatty acids into the mitochondria, is the key rate-limiting process in defatting that was modulated by flow. Therefore, we can ensure higher levels of l-carnitine uptake by the cells by choosing flow rates that minimize the limiting mass transport while minimizing shear stress.
- 20 February 2017
- Published by Springer Nature in Biomechanics and Modeling in Mechanobiology
- Vol. 16 (4) , 1095-1102
CFD assessment of the effect of convective mass transport on the intracellular clearance of intracellular triglycerides in macrosteatotic hepatocytes
Donor livers available to transplant for patients with end-stage liver disease are in severe shortage. One possible avenue to expand the donor pool is to recondition livers that would be otherwise discarded due to excessive fat content. Severely steatotic livers (also known as fatty livers) are highly susceptible to ischemia-reperfusion injury and as a result, primary liver non-function post-transplantation. Prior studies in isolated perfused rat livers suggest that “defatting” may be possible in a timeframe of a few hours; thus, it is conceivable that fatty liver grafts could be recovered by machine perfusion to clear stored fat from the organ prior to transplantation. However, studies using hepatoma cells and adult hepatocytes made fatty in culture report that defatting may take several days. Because cell culture studies were done in static conditions, we hypothesized that the defatting kinetics are highly sensitive to flow-mediated transport of metabolites. To investigate this question, we experimentally evaluated the effect of increasing flow rate on the defatting kinetics of cultured HepG2 cells and developed an in silico combined reaction-transport model to identify possible rate-limiting steps in the defatting process. We found that in cultured fatty HepG2 cells, the time required to clear stored fat down to lean control cells can be reduced from 48 to 4–6 h by switching from static to flow conditions. The flow required resulted in a fluid shear of .008 Pa, which did not adversely affect hepatic function. The reaction-transport model suggests that the transport of l-carnitine, which is the carrier responsible for taking free fatty acids into the mitochondria, is the key rate-limiting process in defatting that was modulated by flow. Therefore, we can ensure higher levels of l-carnitine uptake by the cells by choosing flow rates that minimize the limiting mass transport while minimizing shear stress.
- 27 September 2012
- Published by Springer Nature
- p. 15-38
Mesenchymal Stromal Cell Mechanisms of Immunomodulation and Homing
- 27 September 2012
- Published by Springer Nature
- p. 15-38
Mesenchymal Stromal Cell Mechanisms of Immunomodulation and Homing
- 1 January 2008
- Published by Elsevier in Computers & Chemical Engineering
- Vol. 32 (1-2) , 356-369
Identification of regulatory mechanisms of the hepatic response to thermal injury
- 1 January 2008
- Published by Elsevier in Computers & Chemical Engineering
- Vol. 32 (1-2) , 356-369
Identification of regulatory mechanisms of the hepatic response to thermal injury
- 24 May 2005
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 21606986,p. 213-214
Alginate encapsulation and hepatic differentiation of embryonic stem cells
The emergence of cell based clinical technologies has been limited by the need for large cell masses (>10/sup 11/ cells). Embryonic stem cells are a promising solution to this cell source limitation because they are highly proliferative, renewable and pluripotent. Although many investigators have described techniques to effectively differentiate stem cells into a variety of mature cell lineages, these fall short in a number of ways including: 1) low yields of fully differentiated cells, 2) absence of large scale processing considerations and 3) ineffective downstream enrichment. Thus, a tissue culture microenvironment is required that may be modified to increase regulation of embryonic stem cell differentiation, and scaled to increase differentiated cell yield. Microencapsulation provides a vehicle for the discrete control of key cell culture parameters such as cell seeding density, rigidity, and substrate surface microarchitecture. In order to assess the feasibility of directing stem cell differentiation via microenvironment regulation, we have developed a murine embryonic stem cell (ES) alginate poly-L-lysine microencapsulation differentiation system. Our results indicate that the alginate microenvironment is biocompatible, is conductive to ES cell differentiation, and maintains differentiated cellular function. In addition, changes in alginate concentration and cell seeding density have proven effective in modulating differentiation as well as mature hepatic function.
- 24 May 2005
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 21606986,p. 213-214
Alginate encapsulation and hepatic differentiation of embryonic stem cells
The emergence of cell based clinical technologies has been limited by the need for large cell masses (>10/sup 11/ cells). Embryonic stem cells are a promising solution to this cell source limitation because they are highly proliferative, renewable and pluripotent. Although many investigators have described techniques to effectively differentiate stem cells into a variety of mature cell lineages, these fall short in a number of ways including: 1) low yields of fully differentiated cells, 2) absence of large scale processing considerations and 3) ineffective downstream enrichment. Thus, a tissue culture microenvironment is required that may be modified to increase regulation of embryonic stem cell differentiation, and scaled to increase differentiated cell yield. Microencapsulation provides a vehicle for the discrete control of key cell culture parameters such as cell seeding density, rigidity, and substrate surface microarchitecture. In order to assess the feasibility of directing stem cell differentiation via microenvironment regulation, we have developed a murine embryonic stem cell (ES) alginate poly-L-lysine microencapsulation differentiation system. Our results indicate that the alginate microenvironment is biocompatible, is conductive to ES cell differentiation, and maintains differentiated cellular function. In addition, changes in alginate concentration and cell seeding density have proven effective in modulating differentiation as well as mature hepatic function.